Fig. 4: Consort diagram of the distribution of patients within the curative patient cohort with ctDNA-positive/negative blood samples.

Includes reference to timelines for curative patients shown in Supplementary Fig. 14.

Includes reference to timelines for curative patients shown in Supplementary Fig. 14.